Veterinary biotech

Rumen/gut direct-fed microbials and targeted bacteriophage cocktails are displacing broad-spectrum antibiotics in livestock and poultry, controlling Salmonella, E. coli and Listeria without disrupting the animal's own microbiome.

Species-specific probiotics and heat-stable postbiotics for dog and cat gut health — a $3.2B market driven by pet humanisation, growing at 11% CAGR.

Advanced veterinary biotechnology focusing on mRNA vaccines, recombinant proteins, and novel biologics to combat zoonotic and livestock diseases with rapid-response platforms.

Direct-to-consumer DNA testing of dogs and cats — a stack from cheek-swab collection to a LIMS-verified veterinary genetic passport screening hundreds of inherited disease risks.